Christopher James Roberts - 18 Mar 2026 Form 3 Insider Report for AC Immune SA (ACIU)

Role
Chief Financial Officer
Signature
/s/ Matthias Maurer, attorney-in-fact for Christopher James Roberts
Issuer symbol
ACIU
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 13:09:22 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roberts Christopher James Chief Financial Officer EPFL INNOVATION PARK, BUILDING B, LAUSANNE, SWITZERLAND /s/ Matthias Maurer, attorney-in-fact for Christopher James Roberts 18 Mar 2026 0002112626

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACIU Common Shares 155,382 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 7,200 $5.15 Direct F2
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 7,200 $6.30 Direct F2
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 7,200 $6.88 Direct F2
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 7,200 $2.76 Direct F2
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 29,126 $2.32 Direct F2
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 55,215 $3.99 Direct F3
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 92,308 $2.91 Direct F4
holding ACIU Share Option (right to buy) 18 Mar 2026 Common Shares 89,552 $3.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 109,564 common shares underlying outstanding restricted share units.
F2 The share option is fully vested.
F3 The share option vests in twelve substantially equal quarterly installments beginning on March 31, 2024.
F4 The share option vests in twelve substantially equal quarterly installments beginning on March 31, 2025.
F5 The share option vests in twelve substantially equal quarterly installments beginning on March 31, 2026.

Remarks:

Exhibit 24 - Power of Attorney